Allergy Therapeutics PLC Holding(s) in Company (6554J)
April 08 2015 - 10:47AM
UK Regulatory
TIDMAGY
RNS Number : 6554J
Allergy Therapeutics PLC
08 April 2015
For filings with the FCA include the
annex
For filings with issuer exclude the
annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or the underlying Allergy Therapeutics Plc
issuer
of existing shares to which voting rights
are
attached: (ii)
----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights Yes
----------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments No
which may result in the acquisition of shares already issued to
which voting rights are attached
----------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic No
effect to qualifying financial instruments
----------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights No
----------------------------------------------------------------------------- -------
Other (please No
specify):
------------------- -------------------------------------------------------- -------
3. Full name of person(s) subject Invesco Limited
to the
notification obligation: (iii)
----------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------
5. Date of the transaction and date 31 March 2015
on
which the threshold is crossed
or
reached: (v)
----------------------------------------
6. Date on which issuer notified: 01 April 2015
----------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 5%
----------------------------------------
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type of Situation previous Resulting situation after the triggering
shares to the triggering transaction
transaction
if possible
using
the ISIN CODE
-------------------------------- ----------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
-------------- ---------------- ------------- -------------------------- ---------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
----- ------- ------ -------- ------------- ------------- ----------- -------------- -----------
GB00B02LCQ05 18,016,209 18,016,209 30,685,209 5.62%
-------------- ---------------- ------------- ------------- ----------- -------------- -----------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
--------------- ------------------------------- -------------------------- -------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
---------------- ---------------- --------------- -------------------------- -------------------------
Nominal Delta
---------------- ---------------- --------------- -------------------------- --------------- --------
Total (A+B+C)
Number of voting rights Percentage of voting rights
---------------------------------------------------------
30,685,209 5.62%
---------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
Invesco Asset Management Limited - 30,685,209
Proxy Voting:
10. Name of the proxy holder: Invesco Limited
---------------------------
11. Number of voting rights proxy holder will N/A
cease
to hold:
---------------------------
12. Date on which proxy holder will cease to N/A
hold
voting rights:
---------------------------
13. Additional information:
14. Contact name: Philippa Sadler
--------------------------------------
15. Contact telephone number: 01491 417 447
--------------------------------------
Note: Annex should only be submitted to the FCA not the issuer
Annex: Notification of major interests in shares(xxii)
A: Identity of the persons or legal entity subject to the notification
obligation
Full name
(including legal form of legal entities)
--------------------------------------
Contact address
(registered office for legal entities)
--------------------------------------
Phone number & email
--------------------------------------
Other useful information
(at least legal representative for
legal persons)
--------------------------------------
B: Identity of the notifier, if applicable
Full name Invesco (UK) Limited
--------------------------------------
Contact address Perpetual Park, Perpetual Park Drive,
Henley-on-Thames. Oxon. RG9 1HH
--------------------------------------
Phone number & email 01491 417 000
--------------------------------------
Other useful information Invesco (UK) Limited
(e.g. functional relationship with
the person or legal entity subject
to the notification obligation)
--------------------------------------
C: Additional information
For notes on how to complete form TR-1 please see the FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUWSSRVBASRAR
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024
